Table 1.
Baseline characteristics of all group, and also comparison labaratory, clinical, and physcological differance according to admission month.
| Variables | All group 139 | First: n:45 (march20-april20) | Second n:48 (April20–May20) |
Third n:46 (May20–June20) |
P value |
|---|---|---|---|---|---|
| age | 55(48–64) | 55(49–66) | 53(43.5–62.3) | 56(51–64) | 0.512 |
| Gender (male) | 95(68.3%) | 34(75.6%) | 35(72.9%) | 26(56.5%) | 0.104 |
| Diabetes mellitus | 27(19.4%) | 8(17.8%) | 5(10.4%) | 14(30.4%) | 0.053 |
| Hypertension | 37(26.6%) | 15(33.3%) | 10(20.8%) | 12(26.1%) | 0.393 |
| Hystory of CAD | 25(18%) | 7(15.6%) | 9(18.8%) | 9(19.6%) | 0.871 |
| Dyslipidemia | 37(26.6%) | 14(31.1%) | 11(22.9%) | 12(26.1%) | 0.668 |
| Smoking (any-time) | 102(73.4%) | 31(68.9%) | 31(64.6%) | 40(87%) | 0.035 |
| Symptoms onset time, day-time | 70 (50.4%) | 26(57.8) | 22(45.8%) | 22(47.8%) | 0.472 |
| Symptom-to-admit hospital (minutes) | 120(60–180) | 180(120–360) | 120(60–180) | 105(60–180) | 0.012 |
| Door-to-Wiring duration minutes | 35(29–42) | 38(31–50) | 33(28–45) | 33(29–42) | 0.062 |
| St elevation amount (lead) | 3(3–4) | 3(3–5) | 3(3–4.25) | 3(3–4) | 0.117 |
| Hospitalization duration day | 3-(3–5) | 3(3–6) | 3(3–4) | 4(3–5) | 0.112 |
| Symptom-pain severity | 9(8–10) | 9(8–10) | 9(8–10) | 9(7–10) | 0.442 |
| Chest pain | 139 (100%) | 45(100%) | 48(100%) | 46(100%) | 1.00 |
| Back-pain | 35(25.2) | 12(26.7%) | 12(25%) | 11(23.9%) | 0.955 |
| Sweating | 77(55.4%) | 19(42.2%) | 34(70.8) | 24(52.2%) | 0.018 |
| Dyspne | 21(15.1%) | 2(4.4%) | 10(20.8) | 9(19.6%) | 0.052 |
| Gastrointestinal symptom | 51(36.7%) | 13(28.9%) | 15(31.3%) | 23(50%) | 0.071 |
| Afraid of virus low Intermediate high |
76 (54.7%) 37(26.6%) 26(18.7%) |
27(60.0%) 6(13.3%) 12(26.7%) |
24(50%) 19(39.6%) 5(10.4%) |
25(54.3%) 12(26.1%) 9(19.6%) |
0.045 |
| Preceding angina | 53(38.1%) | 16(35.6%) | 19(39.6%) | 18(39.1%) | 0.910 |
| Infarct localisation (anterior) | 68(48.9%) | 22(48.9%) | 23(47.9%) | 26(56.5%) | 0.662 |
| Admission ef <35 35–50 <50 |
10(7.2%) 84(72.3%) 45 (20.2%) |
6(13.3%) 32(71.1%) 7(15.6%) |
4(8.3%) 24(50%) 20(41.7%) |
1(2.1%) 28(60.9%) 18(39.1%) |
0.01 |
| Use of ambulance | 84 (60.9%) | 26(57.8%) | 26(55.3%) | 32(69.6%) | 0.325 |
| Sedantary life | 61 (43.9%) | 12(26.7%) | 22(45.8%) | 27(58.7%) | 0.008 |
| Systolic BP mmhg | 122(110–135) | 122(110–136) | 124(112–140) | 114(100–129) | 0.066 |
| Diastolic BP mmhg | 73(70–84) | 75(70–84) | 80(70–86) | 73(69–75) | 0.053 |
| Hemoglobin g/dl | 14.6(13.1–15.5) | 14.1(12.9–15.5) | 14.9(13.3–15.8) | 14.5(12.7–15.3) | 0.150 |
| White blood cell | 12.6(9.9–14.9) | 13.2(10.0–15.1) | 12.6(9.9–13.9) | 11.4(9.3–15.0) | 0.742 |
| Platelet per-cubic mm3 | 272(222–338) | 258(227–336) | 284(248–360) | 255(195–299) | 0.041 |
| Creatinine (mg/dl) | 0.85(0.75–1.0) | 0.90(0.80–0.98) | 0.90(0.76–1.0) | 0.81(0.70–1.01) | 0.314 |
| SpO2 | 97(96–97) | 96(96–97) | 97(96–97) | 97(96–97.3) | 0.195 |
| Support from relative | 31(22.3%) | 9(20%) | 16(33.3%) | 6(13%) | 0.055 |
| House person-lived | 3(2–4) | 4(3–5) | 3(2–4) | 3(2–4) | 0.665 |
| Education. low Middle high |
69(49.6%) 23(16.5%) 47(33.8%) |
22(48.9%) 13(28.9%) 10(22.2%) |
23(47.9%) 4(8.3%) 21(43.8%) |
24(52.2%) 6(13%) 16(34.8%) |
0.045 |
| PI-WSUR total | 35(20–49) | 37(27–63) | 36(23–49) | 25(15–44) | 0.005 |
| PI-WSUR C-OCD | 16 (8–27) | 21(11–32) | 16.5(9–26) | 11(5–24) | <0.001 |
| Beck anxiety inventory | 4(2–6) | 6(4–12) | 4(1–5) | 3(2–4) | <0.001 |
| Beck depression inventory | 5 (2–6) | 8(3–14) | 5(2−12) | 4(2–6) | <0.001 |
Data are given in mean ± SD or in numbers with percentages. The one-way ANOVA, Kruskal-Wallis rank sum test, Fisher's exact test and χ2 test were performed. Gastrointestinal symptom (indigestion, and/or nausea and/or vomiting), PI-WSUR:Padua inventory Washington university revision. C-OCD:Contamination obsessive compulsive disorder, BP- blood pressure; CAD- coronary artery disease, CV- cardiovascular; IQR- interquartile range day-time: 8 am-18 pm.